Raynaud's syndrome.
- 3 March 1990
- Vol. 300 (6724) , 553-555
- https://doi.org/10.1136/bmj.300.6724.553
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ, 1989
- Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective studyThe American Journal of Medicine, 1989
- Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunityClinical Immunology and Immunopathology, 1988
- Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.Annals of the Rheumatic Diseases, 1988
- CL115,347, an Analogue of Prostaglandin E2Angiology, 1985
- Nifedipine A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy, in Ischaemic Heart Disease, Hypertension and Related Cardiovascular DisordersDrugs, 1985
- Influence of the Menstrual Cycle on Raynaud's Phenomenon and on Cold Tolerance in Normal WomenAngiology, 1985
- Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3)Biochemical and Biophysical Research Communications, 1983
- Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's diseaseCurrent Medical Research and Opinion, 1982
- BLOOD FIBRINOLYTIC ACTIVITY IN DISEASES OF SMALL BLOOD VESSELS AND THE EFFECT UF LOW MOLECULAR WEIGHT DEXTRANBritish Journal of Dermatology, 1969